Attendees from Four NY / NJ Biopharmas Discussed a Variety of Topics
Therapeutic research and development creates a massive amount of data. Rapid access to information can enable informed decision making and process improvements. But it can be challenging to collect and analyze this type of information, as data is often stored in disparate systems and formats, is varied and complex, and can lack the critical metadata to make it usable in scientific contexts. On Tuesday, 6/20, we hosted a luncheon and roundtable discussion about the challenges and opportunities in data-driven laboratory process improvement. Roundtable participants included Stephen Scypinski, Vice President, Pharmaceutical Technology at Daiichi Sankyo; Erik Rubin, Director, Business Operations Lead, Pharmaceutical Development at Bristol-Myers Squibb; and leaders from other biopharmas in the region. Key themes included:
- Turning Data into Knowledge – More effectively using data collected in the lab to enable informed decision making, risks of ignoring knowledge management, developing a culture around using the knowledge (e.g., asking the right questions), and having the right people with the right skills to analyze the data (data scientists, etc.)
- Regulatory Compliance – Balancing the need to comply with regulations with the desire for the latest technology, opportunities to streamline workflows for collecting and reviewing data, and the importance of process adherence/trust in the system
- Usability – Keeping the end user in mind when building software/systems, approaches for user involvement, and ideas for how to streamline experimental data capture including options for direct data capture
If you weren’t able to attend the event and/or are interested in future events, contact us and let us know! We will be hosting more regional and topical events in the near future.
Thanks again to everyone who came out!